Key statistics
As of last trade Adaptive Biotechnologies Corp (1HM:DUS) traded at 4.11, -23.33% below its 52-week high of 5.35, set on Sep 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.11 |
---|---|
High | 4.11 |
Low | 4.11 |
Bid | 4.10 |
Offer | 4.24 |
Previous close | 4.12 |
Average volume | 0.00 |
---|---|
Shares outstanding | 147.47m |
Free float | 144.53m |
P/E (TTM) | -- |
Market cap | 685.75m USD |
EPS (TTM) | -1.47 USD |
Data delayed at least 15 minutes, as of Sep 23 2024 07:11 BST.
More ▼
Announcements
- Adaptive Announces IVDR Certification for clonoSEQ® in European Union
- Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results
- Adaptive Biotechnologies to Report Second Quarter 2024 Financial Results on August 1, 2024
- Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
- Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
- Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
- Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
- Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
More ▼